OWA
REGN icon

Opal Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Opal Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Sell
340
-14
-4% -$9.53K 0.05% 206
2026
Q1 		$274K Buy
354
+11
+3% +$8.42K 0.06% 160
2025
Q4 		$265K Buy
+343
New +$233K 0.07% 171
2025
Q3 		– Sell
-342
Closed -$180K – 472
2025
Q2 		$180K Buy
342
+98
+40% +$54.7K 0.05% 209
2025
Q1 		$155K Buy
+244
New +$168K 0.05% 209
2024
Q4 		– Sell
-255
Closed -$268K – 203
2024
Q3 		$268K Sell
255
-56
-18% -$62.3K 0.08% 140
2024
Q2 		$327K Buy
+311
New +$301K 0.11% 116

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Opal Wealth Advisors's REGN Position: Q2 2026 in Review

Opal Wealth Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 4% in Q2 2026, selling an estimated $9.53K and leaving 340 shares worth $212K. The position accounts for 0.05% of the portfolio, ranked #206.

Opal Wealth Advisors first reported a position in REGN in Q2 2024 and has held it in 7 quarters since. The position peaked at $327K in Q2 2024. 519 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Opal Wealth Advisors held 340 shares of Regeneron Pharmaceuticals worth $212K as of Q2 2026.
  • Opal Wealth Advisors sold 14 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $9.53K.
  • Regeneron Pharmaceuticals made up 0.05% of Opal Wealth Advisors's portfolio in Q2 2026, its #206 holding.
  • Opal Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Opal Wealth Advisors's Regeneron Pharmaceuticals position peaked at $327K in Q2 2024.
  • 519 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.